Cofactors for human immunodeficiency virus entry into primary macrophages
- PMID: 10099111
- DOI: 10.1086/314797
Cofactors for human immunodeficiency virus entry into primary macrophages
Abstract
Macrophages are permissive for macrophage-tropic (M-tropic) human immunodeficiency virus type 1 (HIV-1) isolates that use CCR5 for entry but are resistant to CXCR-4-dependent T cell-tropic prototype strains. M-tropic variants are critical for HIV-1 transmission, and persons who are homozygous for an inactivating mutation of CCR5 are resistant to HIV-1 in vivo. In vitro, their macrophages and lymphocytes are resistant to M-tropic strains that depend on CCR5. It is shown that CCR5-deficient macrophages are permissive for a dual-tropic isolate, 89.6, that uses CCR5, CXCR-4, and other cofactors. Entry by 89.6 into CCR5-deficient macrophages was blocked by the CXCR-4 ligand SDF and by an anti-CXCR-4 antibody. Immunoflorescence staining and reverse transcription PCR confirmed macrophage CXCR-4 expression. Thus, CXCR-4 on macrophages mediates entry of certain dual-tropic but not T cell-tropic isolates. Therefore, HIV-1 strains differ in how they utilize chemokine receptors as cofactors for entry, and the ability of a chemokine receptor to facilitate entry depends on the cell in which it is expressed.
Similar articles
-
CXCR-4 is expressed by primary macrophages and supports CCR5-independent infection by dual-tropic but not T-tropic isolates of human immunodeficiency virus type 1.J Virol. 1998 Jan;72(1):772-7. doi: 10.1128/JVI.72.1.772-777.1998. J Virol. 1998. PMID: 9420285 Free PMC article.
-
Isolated human astrocytes are not susceptible to infection by M- and T-tropic HIV-1 strains despite functional expression of the chemokine receptors CCR5 and CXCR4.Glia. 2001 May;34(3):165-77. Glia. 2001. PMID: 11329179
-
Role of CCR5 in infection of primary macrophages and lymphocytes by macrophage-tropic strains of human immunodeficiency virus: resistance to patient-derived and prototype isolates resulting from the delta ccr5 mutation.J Virol. 1997 Apr;71(4):3219-27. doi: 10.1128/JVI.71.4.3219-3227.1997. J Virol. 1997. PMID: 9060685 Free PMC article.
-
Co-infection with opportunistic pathogens promotes human immunodeficiency virus type 1 infection in macrophages.J Infect Dis. 1999 May;179 Suppl 3:S457-60. doi: 10.1086/314814. J Infect Dis. 1999. PMID: 10099119 Review.
-
The influence of cytokines, chemokines and their receptors on HIV-1 replication in monocytes and macrophages.Rev Med Virol. 2003 Jan-Feb;13(1):39-56. doi: 10.1002/rmv.369. Rev Med Virol. 2003. PMID: 12516061 Review.
Cited by
-
Cytokine responses to treponema pectinovorum and treponema denticola in human gingival fibroblasts.Infect Immun. 2000 Sep;68(9):5284-92. doi: 10.1128/IAI.68.9.5284-5292.2000. Infect Immun. 2000. PMID: 10948156 Free PMC article.
-
Human retinal microglia express candidate receptors for HIV-1 infection.Br J Ophthalmol. 2005 Jun;89(6):753-7. doi: 10.1136/bjo.2004.057828. Br J Ophthalmol. 2005. PMID: 15923514 Free PMC article.
-
Viral protein U (Vpu)-mediated enhancement of human immunodeficiency virus type 1 particle release depends on the rate of cellular proliferation.J Virol. 2001 Jul;75(14):6714-8. doi: 10.1128/JVI.75.14.6714-6718.2001. J Virol. 2001. PMID: 11413341 Free PMC article.
-
Tissue-resident macrophages are productively infected ex vivo by primary X4 isolates of human immunodeficiency virus type 1.J Virol. 2005 Apr;79(8):5220-6. doi: 10.1128/JVI.79.8.5220-5226.2005. J Virol. 2005. PMID: 15795306 Free PMC article.
-
Discordant effects of interleukin-2 on viral and immune parameters in human immunodeficiency virus-1-infected monocyte-derived mature dendritic cells.Clin Exp Immunol. 2003 May;132(2):289-96. doi: 10.1046/j.1365-2249.2003.02143.x. Clin Exp Immunol. 2003. PMID: 12699419 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
